Similarly, PSMA PET/CT is extensively utilized for the detection of prostate cancer in both soft tissue and bone, yet its detection rate for lymph node metastases measuring 2–5 mm hovers around 60% (40, 41). The gene discussed is FOLH1; the disease is prostate carcinoma.